Cargando…
Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection
The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulator...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423874/ https://www.ncbi.nlm.nih.gov/pubmed/32850913 http://dx.doi.org/10.3389/fmed.2020.00421 |
_version_ | 1783570213938135040 |
---|---|
author | Ouyang, Jing Isnard, Stéphane Lin, John Fombuena, Brandon Peng, Xiaorong Nair Parvathy, Seema Chen, Yaokai Silverman, Michael S. Routy, Jean-Pierre |
author_facet | Ouyang, Jing Isnard, Stéphane Lin, John Fombuena, Brandon Peng, Xiaorong Nair Parvathy, Seema Chen, Yaokai Silverman, Michael S. Routy, Jean-Pierre |
author_sort | Ouyang, Jing |
collection | PubMed |
description | The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulatory functions. Dysregulation of the gut microbiota composition, termed dysbiosis, has been associated with epithelial damage and translocation of microbial products into the circulating blood. Dysbiosis, increased gut permeability and chronic inflammation play a major role on the clinical outcome of inflammatory bowel diseases, graft-vs.-host disease (GVHD) and HIV infection. In this review, we focus on GVHD and HIV infection, conditions sharing gut immune damage leading to dysbiosis. The degree of dysbiosis and level of epithelial gut damage predict poor clinical outcome in both conditions. Emerging interventions are therefore warranted to promote gut microbiota homeostasis and improve intestinal barrier function. Interventions such as anti-inflammatory medications, and probiotics have toxicity and/or limited transitory effects, justifying innovative approaches. Fecal microbiota transplantation (FMT) is one such approach where fecal microorganisms are transferred from healthy donors into the GI tract of the recipient to restore microbiota composition in patients with Clostridium difficile-induced colitis or inflammatory bowel diseases. Preliminary findings point toward a beneficial effect of FMT to improve GVHD and HIV-related outcomes through the engraftment of beneficial donor bacteria, notably those producing anti-inflammatory metabolites. Herein, we critically review the potential for FMT in alleviating dysbiosis and gut damage in patients with GVHD or HIV-infection. Understanding the underlying mechanism by which FMT restores gut function will pave the way toward novel scalable and targeted interventions. |
format | Online Article Text |
id | pubmed-7423874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74238742020-08-25 Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection Ouyang, Jing Isnard, Stéphane Lin, John Fombuena, Brandon Peng, Xiaorong Nair Parvathy, Seema Chen, Yaokai Silverman, Michael S. Routy, Jean-Pierre Front Med (Lausanne) Medicine The gastrointestinal (GI) tract is a complex and well-balanced milieu of anatomic and immunological barriers. The epithelial surface of the GI tract is colonized by trillions of microorganisms, known as the gut microbiota, which is considered an “organ” with distinctive endocrine and immunoregulatory functions. Dysregulation of the gut microbiota composition, termed dysbiosis, has been associated with epithelial damage and translocation of microbial products into the circulating blood. Dysbiosis, increased gut permeability and chronic inflammation play a major role on the clinical outcome of inflammatory bowel diseases, graft-vs.-host disease (GVHD) and HIV infection. In this review, we focus on GVHD and HIV infection, conditions sharing gut immune damage leading to dysbiosis. The degree of dysbiosis and level of epithelial gut damage predict poor clinical outcome in both conditions. Emerging interventions are therefore warranted to promote gut microbiota homeostasis and improve intestinal barrier function. Interventions such as anti-inflammatory medications, and probiotics have toxicity and/or limited transitory effects, justifying innovative approaches. Fecal microbiota transplantation (FMT) is one such approach where fecal microorganisms are transferred from healthy donors into the GI tract of the recipient to restore microbiota composition in patients with Clostridium difficile-induced colitis or inflammatory bowel diseases. Preliminary findings point toward a beneficial effect of FMT to improve GVHD and HIV-related outcomes through the engraftment of beneficial donor bacteria, notably those producing anti-inflammatory metabolites. Herein, we critically review the potential for FMT in alleviating dysbiosis and gut damage in patients with GVHD or HIV-infection. Understanding the underlying mechanism by which FMT restores gut function will pave the way toward novel scalable and targeted interventions. Frontiers Media S.A. 2020-08-06 /pmc/articles/PMC7423874/ /pubmed/32850913 http://dx.doi.org/10.3389/fmed.2020.00421 Text en Copyright © 2020 Ouyang, Isnard, Lin, Fombuena, Peng, Nair Parvathy, Chen, Silverman and Routy. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Medicine Ouyang, Jing Isnard, Stéphane Lin, John Fombuena, Brandon Peng, Xiaorong Nair Parvathy, Seema Chen, Yaokai Silverman, Michael S. Routy, Jean-Pierre Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title | Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title_full | Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title_fullStr | Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title_full_unstemmed | Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title_short | Treating From the Inside Out: Relevance of Fecal Microbiota Transplantation to Counteract Gut Damage in GVHD and HIV Infection |
title_sort | treating from the inside out: relevance of fecal microbiota transplantation to counteract gut damage in gvhd and hiv infection |
topic | Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7423874/ https://www.ncbi.nlm.nih.gov/pubmed/32850913 http://dx.doi.org/10.3389/fmed.2020.00421 |
work_keys_str_mv | AT ouyangjing treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT isnardstephane treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT linjohn treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT fombuenabrandon treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT pengxiaorong treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT nairparvathyseema treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT chenyaokai treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT silvermanmichaels treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection AT routyjeanpierre treatingfromtheinsideoutrelevanceoffecalmicrobiotatransplantationtocounteractgutdamageingvhdandhivinfection |